Recent Company News

• 07:02 AM ET Dec 11, 2025
  

  Construction/materials, industrials, healthcare best performers; tech, utilities and autos main laggards:

• 04:14 AM ET Nov 27, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 11:49 AM ET Dec 10, 2025
  

  Valneva's Chikungunya vaccine IXCHIQ demonstrates strong antibody persistence and safety in children in final Phase 2 results. (€3.77, 0.00)

• 08:15 AM ET Nov 27, 2025
  

  Financial Services, Autos/Parts and Real Estate lead; Healthcare, Personal/HHold Goods and Utilities lag:

• 02:55 AM ET Nov 27, 2025
  

  StreetAccount Summary - European pre-market trading update

• 11:32 AM ET Nov 26, 2025
  

  Valneva announces strategic initiative to optimize its organizational footprint in France as part of ongoing efforts to increase operational effectiveness (€4.05, 0.00)

• 09:15 AM ET Nov 26, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 08:31 AM ET Nov 26, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 08:21 AM ET Nov 26, 2025
  

  Banks, Basic Resources and Technology lead; Media, Food/Beverage and Autos/Parts lag: